COMP <GO>
GYRE vs NGNE // PIOTROSKI F-SCORE QUALITY
Gyre Therapeutics Inc. (NASDAQ) VS. Neurogene Inc. (NASDAQ) • 15-METRIC TALLY: GYRE 4
— NGNE 2
▲ PIOTROSKI F-SCORE QUALITY LEADER: GYRE
LAST: $4.44 (-6.13%) • MKT CAP: $527.4M
piotroski-score
5/9
LAST: $26.67 (+0.23%) • MKT CAP: $532.5M
piotroski-score
2/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GYRE VS. NGNE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GYRE | NGNE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 95.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.40% | -35.00% | +60.40 | GYRE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 53.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.03% | -13.59% | +13.56 | GYRE | /fcf-yield <GO> |
| Operating Margin | 9.90% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 8.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 10.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.33 | 12.76 | +1.57 | GYRE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 2/9 | +3.00 | GYRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.5 | 48.0 | -8.50 | NGNE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 67.2x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $527.4M | $532.5M | -$5.1M | NGNE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GYRE REV | NGNE REV | GYRE GROSS % | NGNE GROSS % | GYRE FCF | NGNE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $116.6M | $289.3M | 95.4% | — | -$180.0K | -$78.4M |
| FY 2024 | $105.8M | $925.0K | 96.3% | — | -$6.0M | -$71.4M |
| FY 2023 | $113.5M | $155.6M | — | — | $25.9M | -$51.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GYRE // BETA —
NGNE // BETA —